DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury.
Zhang L, Zhang Q, Liu S, Chen Y, Li R, Lin T, Yu C, Zhang H, Huang Z, Zhao X, Tan X, Li Z, Ye Z, Ma J, Zhang B, Wang W, Shi W, Liang X.
Zhang L, et al. Among authors: wang w.
Kidney Int. 2017 Jul;92(1):140-153. doi: 10.1016/j.kint.2017.01.010. Epub 2017 Mar 15.
Kidney Int. 2017.
PMID: 28318634
Free article.